| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
57,728 |
45,463 |
$3.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,375 |
18,535 |
$1.81M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,783 |
7,196 |
$770K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,911 |
2,626 |
$422K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,150 |
3,434 |
$163K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,193 |
2,904 |
$98K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
659 |
630 |
$76K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
528 |
491 |
$62K |
| 99051 |
|
8,541 |
7,680 |
$54K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
863 |
734 |
$54K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,630 |
2,330 |
$31K |
| 93000 |
|
2,336 |
2,159 |
$28K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,609 |
2,380 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,164 |
1,954 |
$21K |
| 99050 |
|
1,584 |
1,456 |
$19K |
| 90674 |
|
976 |
836 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
118 |
109 |
$13K |
| 99173 |
|
1,970 |
1,764 |
$11K |
| 90686 |
|
1,069 |
912 |
$8K |
| 99385 |
|
46 |
44 |
$6K |
| 96127 |
|
412 |
388 |
$6K |
| 99215 |
Prolong outpt/office vis |
43 |
41 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
38 |
37 |
$4K |
| 99201 |
|
110 |
104 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
175 |
167 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
281 |
259 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,419 |
1,297 |
$2K |
| 99454 |
|
184 |
181 |
$2K |
| 81000 |
|
556 |
472 |
$1K |
| 99457 |
|
126 |
126 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
348 |
335 |
$1K |
| 90715 |
|
37 |
36 |
$671.91 |
| 86580 |
|
104 |
99 |
$600.96 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$457.16 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
271 |
249 |
$445.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
44 |
$316.72 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17 |
14 |
$252.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,806 |
6,842 |
$211.14 |
| 81025 |
|
24 |
24 |
$144.96 |
| 99453 |
|
18 |
18 |
$97.27 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$41.78 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
74 |
71 |
$35.46 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
39 |
37 |
$0.84 |
| 81002 |
|
102 |
96 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
78 |
77 |
$0.00 |
| 99000 |
|
113 |
106 |
$0.00 |